Lantern Pharma Inc. - Common Stock (LTRN)
4.9500
+0.1400 (2.91%)
Lantern Pharma Inc is a biotechnology company focused on leveraging artificial intelligence and machine learning to accelerate the drug discovery and development process, particularly for oncology therapeutics
The company aims to identify and develop personalized treatment options that target specific patient populations based on their genetic profiles and responses to various therapies. By harnessing advanced technologies, Lantern Pharma seeks to streamline clinical trials and bring innovative cancer treatments to market more efficiently, ultimately improving patient outcomes and advancing the field of precision medicine.
Frequently Asked Questions
Is Lantern Pharma Inc. - Common Stock publicly traded?
Yes, Lantern Pharma Inc. - Common Stock is publicly traded.
What exchange does Lantern Pharma Inc. - Common Stock trade on?
Lantern Pharma Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lantern Pharma Inc. - Common Stock?
The ticker symbol for Lantern Pharma Inc. - Common Stock is LTRN on the Nasdaq Stock Market
What is the current price of Lantern Pharma Inc. - Common Stock?
The current price of Lantern Pharma Inc. - Common Stock is 4.950
When was Lantern Pharma Inc. - Common Stock last traded?
The last trade of Lantern Pharma Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025